It recently completed a trial in liver cancer that significantly improved patients' survival rates, Kirn says.
Kirn说在最近完成的一项针对肝癌的试验中，患者的存活率显著提高。
Kirn said the study opens the door to retest existing genetic or protein treatments that had previously been limited to patients with localized tumors.
Kirn说，基因和蛋白疗法之前仅限于局部使用，而此项研究则开启了对其进行重新评估的大门。
应用推荐